CN Stock MarketDetailed Quotes

603939 Yifeng Pharmacy Chain

Watchlist
  • 25.18
  • +0.85+3.49%
Not Open Dec 12 15:00 CST
30.53BMarket Cap20.05P/E (TTM)

Yifeng Pharmacy Chain Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
8.38%17.22B
9.86%11.76B
13.39%5.97B
13.59%22.59B
19.03%15.89B
22.36%10.71B
26.94%5.27B
29.75%19.89B
22.03%13.35B
19.11%8.75B
Operating revenue
8.38%17.22B
9.86%11.76B
13.39%5.97B
13.59%22.59B
19.03%15.89B
22.36%10.71B
26.94%5.27B
29.75%19.89B
22.03%13.35B
19.11%8.75B
Other operating revenue
----
30.14%367.28M
----
1.20%510.66M
----
12.39%282.23M
----
-2.77%504.62M
----
-7.45%251.1M
Total operating cost
8.57%15.71B
9.81%10.68B
12.79%5.39B
14.48%20.62B
19.13%14.47B
22.93%9.72B
27.68%4.78B
28.21%18.01B
22.16%12.15B
19.36%7.91B
Operating cost
6.86%10.26B
9.76%7.05B
14.17%3.63B
16.07%13.96B
21.82%9.6B
24.17%6.42B
29.70%3.18B
31.53%12.03B
22.46%7.88B
19.05%5.17B
Operating tax surcharges
19.69%69.01M
28.24%48.21M
29.15%23.14M
27.23%89.39M
19.17%57.66M
17.07%37.59M
23.47%17.92M
27.04%70.26M
26.46%48.39M
28.42%32.11M
Operating expense
10.44%4.48B
9.23%3.01B
8.07%1.46B
12.49%5.49B
13.82%4.05B
20.77%2.75B
25.06%1.35B
20.16%4.88B
23.04%3.56B
21.05%2.28B
Administration expense
11.38%756.15M
4.71%481.53M
16.09%249.12M
6.46%962.42M
21.85%678.91M
27.33%459.89M
24.06%214.58M
37.54%904.06M
16.27%557.17M
17.36%361.2M
Financial expense
94.31%122.43M
85.83%73.08M
38.98%28M
-17.77%86.18M
-24.76%63.01M
-27.32%39.33M
-24.15%20.15M
-8.76%104.81M
-2.70%83.74M
-8.79%54.11M
-Interest expense (Financial expense)
30.46%159.59M
28.59%102.74M
11.81%44.36M
-2.83%160.53M
-4.71%122.33M
-1.09%79.9M
3.45%39.67M
-2.24%165.21M
-0.91%128.38M
-11.00%80.78M
-Interest Income (Financial expense)
23.60%-55.48M
16.81%-42.02M
10.94%-22.13M
-27.43%-93.29M
-37.48%-72.62M
-58.99%-50.51M
-76.68%-24.85M
-14.13%-73.21M
-4.19%-52.82M
13.77%-31.77M
Research and development
65.08%25.19M
71.11%16.87M
110.72%9.77M
32.56%33.55M
10.79%15.26M
7.13%9.86M
11.08%4.64M
61.80%25.31M
53.45%13.77M
62.11%9.2M
Credit Impairment Loss
-632.93%-2.15M
-122.01%-526.56K
6.97%3.11M
56.65%-4.54M
115.97%404.12K
175.01%2.39M
504.47%2.91M
-137.10%-10.47M
26.48%-2.53M
-27.20%-3.19M
Asset Impairment Loss
-11.78%-59.75M
-12.10%-38.8M
-14.37%-19.3M
-29.66%-72.63M
-36.11%-53.46M
-28.76%-34.61M
-11.85%-16.88M
-37.48%-56.02M
-37.90%-39.28M
-41.64%-26.88M
Adjustment items of total operating cost
----
----
0.00%-0.01
----
----
----
---0.01
----
----
----
Other net revenue
49.91%78.66M
-1.52%48.46M
-6.94%17.13M
1,021.85%83.16M
204.46%52.47M
410.78%49.2M
277.83%18.41M
-87.26%7.41M
-54.28%17.23M
-61.13%9.63M
Invest income
111.89%76.8M
65.79%49.45M
224.32%14.93M
516.89%42.37M
394.66%36.25M
339.34%29.83M
115.05%4.6M
-80.01%6.87M
-74.62%7.33M
-65.90%6.79M
-Including: Investment income associates
39.10%-974.75
42.22%-903.14
-1,277.48%-453.88
2,873.81%316.57K
85.95%-1.6K
86.24%-1.56K
---32.95
---11.41K
---11.39K
---11.36K
Asset deal income
2.64%22.82M
-2.77%14.95M
48.19%6.78M
80.51%41.82M
67.19%22.23M
170.72%15.38M
236.48%4.58M
238.25%23.17M
309.72%13.3M
317.19%5.68M
Other revenue
-12.97%40.94M
-35.43%23.38M
-49.94%11.62M
73.58%76.13M
22.46%47.05M
32.99%36.22M
35.06%23.2M
-29.42%43.86M
2.46%38.42M
8.93%27.23M
Operating profit
7.95%1.59B
9.80%1.13B
18.31%593.52M
8.98%2.05B
20.65%1.47B
21.43%1.03B
23.16%501.65M
40.83%1.89B
18.00%1.22B
14.17%850.44M
Add:Non operating Income
14.64%8.13M
16.74%5.41M
71.30%2.45M
3.78%12.7M
-28.24%7.09M
-33.34%4.64M
-30.11%1.43M
23.46%12.24M
35.91%9.88M
59.92%6.95M
Less:Non operating expense
68.84%13.68M
39.13%7.88M
20.62%2.74M
47.36%29.9M
7.57%8.1M
36.37%5.67M
8.76%2.27M
86.52%20.29M
3.81%7.53M
-18.06%4.15M
Total profit
7.64%1.58B
9.67%1.13B
18.45%593.24M
8.53%2.04B
20.34%1.47B
20.92%1.03B
22.97%500.82M
40.33%1.88B
18.22%1.22B
14.66%853.24M
Less:Income tax cost
12.38%381.57M
16.57%271.43M
21.78%147.29M
0.57%456.66M
11.99%339.54M
9.46%232.84M
14.71%120.95M
30.79%454.06M
15.29%303.2M
12.27%212.71M
Net profit
6.22%1.2B
7.66%860.07M
17.40%445.95M
11.07%1.58B
23.10%1.13B
24.72%798.86M
25.85%379.87M
43.67%1.42B
19.23%916.53M
15.47%640.54M
Net profit from continuing operation
6.22%1.2B
7.66%860.07M
17.40%445.95M
11.07%1.58B
23.10%1.13B
24.72%798.86M
25.85%379.87M
43.67%1.42B
19.23%916.53M
15.47%640.54M
Less:Minority Profit
-31.89%87.92M
-33.46%62.35M
-9.66%39.2M
4.56%168.95M
38.91%129.08M
46.16%93.71M
46.50%43.39M
57.09%161.58M
27.72%92.93M
28.34%64.11M
Net profit of parent company owners
11.14%1.11B
13.13%797.72M
20.89%406.75M
11.90%1.41B
21.32%999.18M
22.33%705.15M
23.60%336.48M
42.12%1.26B
18.34%823.6M
14.20%576.42M
Add:Adjusted items effecting net profit of parent company owners
----
---0.01
----
----
----
----
--0.01
----
----
----
Earning per share
Basic earning per share
10.84%0.92
13.79%0.66
17.65%0.4
11.11%1.4
1.22%0.83
1.75%0.58
-10.53%0.34
0.80%1.26
-16.33%0.82
-21.60%0.57
Diluted earning per share
10.84%0.92
13.79%0.66
17.65%0.4
12.00%1.4
2.47%0.83
1.75%0.58
-10.53%0.34
0.81%1.25
-16.49%0.81
-20.50%0.57
Other composite income
-205.31%-89.37M
-176.03%-119.8M
-148.79%-44.2M
325.97%38.42M
299.62%84.87M
2,724.71%157.58M
90.61M
-17M
-42.51M
-6M
Other composite income of parent company owners
-205.31%-89.37M
-176.03%-119.8M
-148.79%-44.2M
325.97%38.42M
299.62%84.87M
2,724.71%157.58M
--90.61M
---17M
---42.51M
---6M
Total composite income
-8.58%1.11B
-22.60%740.27M
-14.61%401.75M
15.14%1.62B
38.80%1.21B
50.73%956.44M
55.87%470.48M
41.96%1.41B
13.70%874.01M
14.39%634.53M
Total composite income of parent company owners
-5.80%1.02B
-21.42%677.92M
-15.11%362.55M
16.51%1.45B
38.79%1.08B
51.24%862.73M
56.88%427.08M
40.20%1.24B
12.23%781.09M
13.01%570.42M
Total composite income of minority owners
-31.89%87.92M
-33.46%62.35M
-9.66%39.2M
4.56%168.95M
38.91%129.08M
46.16%93.71M
46.50%43.39M
57.09%161.58M
27.72%92.93M
28.34%64.11M
Add:Adjusted items effecting total composite income
----
---0.01
----
----
----
----
--0.01
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 8.38%17.22B9.86%11.76B13.39%5.97B13.59%22.59B19.03%15.89B22.36%10.71B26.94%5.27B29.75%19.89B22.03%13.35B19.11%8.75B
Operating revenue 8.38%17.22B9.86%11.76B13.39%5.97B13.59%22.59B19.03%15.89B22.36%10.71B26.94%5.27B29.75%19.89B22.03%13.35B19.11%8.75B
Other operating revenue ----30.14%367.28M----1.20%510.66M----12.39%282.23M-----2.77%504.62M-----7.45%251.1M
Total operating cost 8.57%15.71B9.81%10.68B12.79%5.39B14.48%20.62B19.13%14.47B22.93%9.72B27.68%4.78B28.21%18.01B22.16%12.15B19.36%7.91B
Operating cost 6.86%10.26B9.76%7.05B14.17%3.63B16.07%13.96B21.82%9.6B24.17%6.42B29.70%3.18B31.53%12.03B22.46%7.88B19.05%5.17B
Operating tax surcharges 19.69%69.01M28.24%48.21M29.15%23.14M27.23%89.39M19.17%57.66M17.07%37.59M23.47%17.92M27.04%70.26M26.46%48.39M28.42%32.11M
Operating expense 10.44%4.48B9.23%3.01B8.07%1.46B12.49%5.49B13.82%4.05B20.77%2.75B25.06%1.35B20.16%4.88B23.04%3.56B21.05%2.28B
Administration expense 11.38%756.15M4.71%481.53M16.09%249.12M6.46%962.42M21.85%678.91M27.33%459.89M24.06%214.58M37.54%904.06M16.27%557.17M17.36%361.2M
Financial expense 94.31%122.43M85.83%73.08M38.98%28M-17.77%86.18M-24.76%63.01M-27.32%39.33M-24.15%20.15M-8.76%104.81M-2.70%83.74M-8.79%54.11M
-Interest expense (Financial expense) 30.46%159.59M28.59%102.74M11.81%44.36M-2.83%160.53M-4.71%122.33M-1.09%79.9M3.45%39.67M-2.24%165.21M-0.91%128.38M-11.00%80.78M
-Interest Income (Financial expense) 23.60%-55.48M16.81%-42.02M10.94%-22.13M-27.43%-93.29M-37.48%-72.62M-58.99%-50.51M-76.68%-24.85M-14.13%-73.21M-4.19%-52.82M13.77%-31.77M
Research and development 65.08%25.19M71.11%16.87M110.72%9.77M32.56%33.55M10.79%15.26M7.13%9.86M11.08%4.64M61.80%25.31M53.45%13.77M62.11%9.2M
Credit Impairment Loss -632.93%-2.15M-122.01%-526.56K6.97%3.11M56.65%-4.54M115.97%404.12K175.01%2.39M504.47%2.91M-137.10%-10.47M26.48%-2.53M-27.20%-3.19M
Asset Impairment Loss -11.78%-59.75M-12.10%-38.8M-14.37%-19.3M-29.66%-72.63M-36.11%-53.46M-28.76%-34.61M-11.85%-16.88M-37.48%-56.02M-37.90%-39.28M-41.64%-26.88M
Adjustment items of total operating cost --------0.00%-0.01---------------0.01------------
Other net revenue 49.91%78.66M-1.52%48.46M-6.94%17.13M1,021.85%83.16M204.46%52.47M410.78%49.2M277.83%18.41M-87.26%7.41M-54.28%17.23M-61.13%9.63M
Invest income 111.89%76.8M65.79%49.45M224.32%14.93M516.89%42.37M394.66%36.25M339.34%29.83M115.05%4.6M-80.01%6.87M-74.62%7.33M-65.90%6.79M
-Including: Investment income associates 39.10%-974.7542.22%-903.14-1,277.48%-453.882,873.81%316.57K85.95%-1.6K86.24%-1.56K---32.95---11.41K---11.39K---11.36K
Asset deal income 2.64%22.82M-2.77%14.95M48.19%6.78M80.51%41.82M67.19%22.23M170.72%15.38M236.48%4.58M238.25%23.17M309.72%13.3M317.19%5.68M
Other revenue -12.97%40.94M-35.43%23.38M-49.94%11.62M73.58%76.13M22.46%47.05M32.99%36.22M35.06%23.2M-29.42%43.86M2.46%38.42M8.93%27.23M
Operating profit 7.95%1.59B9.80%1.13B18.31%593.52M8.98%2.05B20.65%1.47B21.43%1.03B23.16%501.65M40.83%1.89B18.00%1.22B14.17%850.44M
Add:Non operating Income 14.64%8.13M16.74%5.41M71.30%2.45M3.78%12.7M-28.24%7.09M-33.34%4.64M-30.11%1.43M23.46%12.24M35.91%9.88M59.92%6.95M
Less:Non operating expense 68.84%13.68M39.13%7.88M20.62%2.74M47.36%29.9M7.57%8.1M36.37%5.67M8.76%2.27M86.52%20.29M3.81%7.53M-18.06%4.15M
Total profit 7.64%1.58B9.67%1.13B18.45%593.24M8.53%2.04B20.34%1.47B20.92%1.03B22.97%500.82M40.33%1.88B18.22%1.22B14.66%853.24M
Less:Income tax cost 12.38%381.57M16.57%271.43M21.78%147.29M0.57%456.66M11.99%339.54M9.46%232.84M14.71%120.95M30.79%454.06M15.29%303.2M12.27%212.71M
Net profit 6.22%1.2B7.66%860.07M17.40%445.95M11.07%1.58B23.10%1.13B24.72%798.86M25.85%379.87M43.67%1.42B19.23%916.53M15.47%640.54M
Net profit from continuing operation 6.22%1.2B7.66%860.07M17.40%445.95M11.07%1.58B23.10%1.13B24.72%798.86M25.85%379.87M43.67%1.42B19.23%916.53M15.47%640.54M
Less:Minority Profit -31.89%87.92M-33.46%62.35M-9.66%39.2M4.56%168.95M38.91%129.08M46.16%93.71M46.50%43.39M57.09%161.58M27.72%92.93M28.34%64.11M
Net profit of parent company owners 11.14%1.11B13.13%797.72M20.89%406.75M11.90%1.41B21.32%999.18M22.33%705.15M23.60%336.48M42.12%1.26B18.34%823.6M14.20%576.42M
Add:Adjusted items effecting net profit of parent company owners -------0.01------------------0.01------------
Earning per share
Basic earning per share 10.84%0.9213.79%0.6617.65%0.411.11%1.41.22%0.831.75%0.58-10.53%0.340.80%1.26-16.33%0.82-21.60%0.57
Diluted earning per share 10.84%0.9213.79%0.6617.65%0.412.00%1.42.47%0.831.75%0.58-10.53%0.340.81%1.25-16.49%0.81-20.50%0.57
Other composite income -205.31%-89.37M-176.03%-119.8M-148.79%-44.2M325.97%38.42M299.62%84.87M2,724.71%157.58M90.61M-17M-42.51M-6M
Other composite income of parent company owners -205.31%-89.37M-176.03%-119.8M-148.79%-44.2M325.97%38.42M299.62%84.87M2,724.71%157.58M--90.61M---17M---42.51M---6M
Total composite income -8.58%1.11B-22.60%740.27M-14.61%401.75M15.14%1.62B38.80%1.21B50.73%956.44M55.87%470.48M41.96%1.41B13.70%874.01M14.39%634.53M
Total composite income of parent company owners -5.80%1.02B-21.42%677.92M-15.11%362.55M16.51%1.45B38.79%1.08B51.24%862.73M56.88%427.08M40.20%1.24B12.23%781.09M13.01%570.42M
Total composite income of minority owners -31.89%87.92M-33.46%62.35M-9.66%39.2M4.56%168.95M38.91%129.08M46.16%93.71M46.50%43.39M57.09%161.58M27.72%92.93M28.34%64.11M
Add:Adjusted items effecting total composite income -------0.01------------------0.01------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme E-commerce Concept
E-commerce Concept
Intraday+2.24%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+1.79%
MSCI concept
MSCI concept
Intraday+1.06%